Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions

Urothelial CancerMetastatic Solid Tumor

Interventions

DRUG

Colchicine

Patients will receive 14 days of colchicine in the absence of prohibitive toxicity of disease progression

Trial Locations (1)

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER